These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3646300)

  • 1. Physiologic dynamics of acquired valvular heart disease.
    Schakenbach LH
    J Cardiovasc Nurs; 1987 May; 1(3):1-17. PubMed ID: 3646300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recognizing and understanding illnesses: heart sounds as the primary marker].
    Lindner UK
    Pflege Z; 2010 Feb; 63(2):116-8. PubMed ID: 20218172
    [No Abstract]   [Full Text] [Related]  

  • 3. Valvular disease in pregnancy.
    Austin DA; Davis PA
    J Perinat Neonatal Nurs; 1991 Sep; 5(2):13-24. PubMed ID: 1880740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valvular heart disease in the elderly.
    Johnson J
    J Cardiovasc Nurs; 1987 Feb; 1(2):72-81. PubMed ID: 3646297
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital valvular heart disease.
    Lawrence PA; Wieczorek BH
    J Cardiovasc Nurs; 1987 May; 1(3):18-25. PubMed ID: 3646301
    [No Abstract]   [Full Text] [Related]  

  • 6. AANA Journal course: update for nurse anesthetists--anesthetic techniques for patients with valvular heart disease presenting for noncardiac procedures.
    Pemerton AT
    AANA J; 1993 Jun; 61(3):315-24. PubMed ID: 8291393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nursing process: nursing of patients with heart valve diseases. Physiopathology of heart valve diseases].
    Kawase M
    Kurinikaru Sutadi; 1982 Nov; 3(11):1281-8. PubMed ID: 6925670
    [No Abstract]   [Full Text] [Related]  

  • 8. [The future of catheterization in acquired heart valve diseases].
    Delaye J; Okitokoma D; Gayet JL; Pourchaire J
    Ann Cardiol Angeiol (Paris); 1984 Jan; 33(1):11-7. PubMed ID: 6364948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valvular Heart Disease: Current Treatment and Future Perspectives. Topics: I. Diagnosis; 1. Physical examination for valvular heart disease].
    Isobe M
    Nihon Naika Gakkai Zasshi; 2016 Feb; 105(2):184-91. PubMed ID: 27228714
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive Hemodynamics of Valvular Heart Disease.
    Pighi M; Asgar AW
    Interv Cardiol Clin; 2017 Jul; 6(3):319-327. PubMed ID: 28600087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart sounds: are you listening? Part 2.
    Reimer-Kent J
    Can J Cardiovasc Nurs; 2013; 23(3):3-9. PubMed ID: 23984480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease.
    Cheitlin MD; Bonow RO; Parmley WW; Roberts WC; Swan HJ; Williams JF
    J Am Coll Cardiol; 1985 Dec; 6(6):1209-14. PubMed ID: 2856840
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of aging on the diagnostic assessment of valvular heart disease.
    Strom JA; VanAuker MD; Carabello BA
    Am J Geriatr Cardiol; 2006; 15(5):286-90. PubMed ID: 16957447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valvular heart disease: diagnosis and management.
    Bhandari S; Subramanyam K; Trehan N
    J Assoc Physicians India; 2007 Aug; 55():575-84. PubMed ID: 18019800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of pharmacologic or exercise stress echocardiography for the assessment of hemodynamics in valvular heart disease].
    Sicari R; La Falce S
    G Ital Cardiol (Rome); 2011 Oct; 12(10):645-51. PubMed ID: 21947107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    J Am Coll Cardiol; 1994 Oct; 24(4):874-80. PubMed ID: 7930219
    [No Abstract]   [Full Text] [Related]  

  • 17. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease.
    Cheitlin MD; Douglas PS; Parmley WW
    Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748
    [No Abstract]   [Full Text] [Related]  

  • 18. Doppler echocardiographic diagnosis and quantification of valvular heart disease.
    Richards KL
    Curr Probl Cardiol; 1985 Feb; 10(2):1-49. PubMed ID: 3159549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult valvular heart disease: a practical approach.
    Cannistra AJ
    Prim Care; 2005 Dec; 32(4):1109-14, ix. PubMed ID: 16326229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valvular heart disease: a review for nurse anesthetists.
    DeVane GG
    CRNA; 1996 Feb; 7(1):14-24. PubMed ID: 8680350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.